An interventional study of PROMs in Degenerative Diseases, Spinal Cord, sponsored by Centro Hospitalar De São João, E.P.E.. Completed at 2 sites in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-04.
Sponsored by Centro Hospitalar De São João, E.P.E. · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate whether postoperative PROM scores of spine patients are influenced by memory bias
436 studies on the registry are indexed under Neurodegenerative Diseases; 143 are open to participants now.
This study's enrollment of 236 is above the median of 54 across 265 interventional studies indexed under Neurodegenerative Diseases.
Browse Neurodegenerative Diseases studies →Centro Hospitalar De São João, E.P.E. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
no recall PROMs group ; without knowledge of previous PROMs scores
recall PROMs group ; with knowledge of previous PROMs scores
Behavioral: PROMs
evaluate the impact of recall bias on post proms scores
Median COMI score results
Core outcome measures index. Scale 0 to 10 where 0 means the best score
Time frame: 4 weeks
Median ODI score
Neck disability index Oswestry disability index. Scale 0 to 100 where 0 means the worst score
Time frame: 4 weeks
Median EQ-5D score
EuroQol 5 D where 1 is the best score and -0,500 the worst score
Time frame: 4 weeks
Median NDI
Neck disability index Scale 0 to 100 where 0 means the worst score
Time frame: 4 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jan 2021 to primary completion in Sep 2021, 8 months.
Of 75 non-industry interventional studies with no phase under Neurodegenerative Diseases, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 57. This study's 8 months is below that.
Counting every sponsor, half of 82 studies reached it within 35 months; a quarter within 11 and three quarters within 67.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centro Hospitalar De São João, E.P.E.